# CEFTRIAXONE
> **ANDA210197** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2024-01-12
## Drug
- **FDA Application Number:** ANDA210197
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEFTRIAXONE
- **Generic name:** Ceftriaxone Sodium
- **Active ingredients:** CEFTRIAXONE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** DEVA HOLDING AS
- **First approval:** 2024-01-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210197)
---
*MORVS · CC0 1.0*